Forte Biosciences (FBRX) Earnings Analysis

Forte Biosciences (FBRX) next reports earnings on 2026-08-13, consensus EPS -0.9248 USD. Last quarter (2026-05-21) it missed with EPS -1.24 USD vs -1.16 USD est (-6.9%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E -12.36.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does FBRX next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.9248 USD
Revenue estimaten/a

FBRX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-21-1.24 USD-1.16 USD-6.9%Miss
2026-03-31-1.45 USD-1.42 USD-2.1%Miss
2025-11-14-0.99 USD-1.04 USD+4.8%Beat
2025-08-14-0.96 USD-1.21 USD+20.7%Beat
2025-05-15-1.37 USD-0.89 USD-53.9%Miss
2025-03-24-2.45 USD-4.55 USD+46.2%Beat
2024-11-14-4.54 USD-6.75 USD+32.7%Beat
2024-08-14-6.75 USD-4 USD-68.8%Miss

Beat rate: 4/8 (50%) over reported quarters with consensus data.

FBRX valuation and analyst view

Trailing P/E-12.36
Trailing EPS-0.42526 USD
Price / book239.94
Dividend yield0.00%
Market cap0.70B
Analyst consensusBuy (3 buy / 3 hold / 0 sell)
Avg price target74 USD

Related research pages

Frequently asked questions

When is Forte Biosciences (FBRX)'s next earnings date?

Forte Biosciences is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.9248 USD.

Did FBRX beat earnings last quarter?

In its 2026-05-21 report, FBRX posted EPS of -1.24 USD versus a -1.16 USD estimate — a miss of 6.9%.

What is FBRX's earnings track record?

Over the last 8 reported quarters with consensus data, FBRX beat estimates 4 times (50%).

What is FBRX's current P/E ratio and EPS?

FBRX trades at a trailing P/E of -12.36 on trailing EPS of -0.425258022382851 USD.

What do analysts rate FBRX?

Analyst consensus is "Buy" across 6 ratings (0 strong buy, 3 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 74 USD.